Literature DB >> 29589534

The Role of Inflammation in Neurological Disorders.

Diana Degan1, Raffaele Ornello1, Cindy Tiseo1, Antonio Carolei1, Simona Sacco1, Francesca Pistoia1.   

Abstract

Traditionally neurological diseases have been classified, on the basis of their pathogenesis, into vascular, degenerative, inflammatory and traumatic diseases. Examples of the main inflammatory neurological diseases include multiple sclerosis, which is characterized by an immune-mediated response against myelin proteins, and meningoencephalitis, where the inflammatory response is triggered by infectious agents. However, recent evidence suggests a potential role of inflammatory mechanisms also in neurological conditions not usually categorized as inflammatory, such as Alzheimer's disease, Parkinson's disease, Huntington' disease, amyotrophic lateral sclerosis, stroke and traumatic brain injuries. The activation of glial cells and of complement-mediated pathways, the synthesis of inflammation mediators, and the recruitment of leukocytes are the key elements of secondary inflammatory injury following a wide spectrum of primary brain injuries. A better understanding of the role that inflammatory processes play in the natural history of diseases is essential in order to identify potential therapeutic targets and to develop integrated pharmacological approaches acting at different levels and stages of the diseases. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Inflammation; neurodegeneration; neuroprotective; stroke; therapeutic; traumatic.

Mesh:

Substances:

Year:  2018        PMID: 29589534     DOI: 10.2174/1381612824666180327170632

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  16 in total

Review 1.  Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside.

Authors:  Awanish Mishra; Ritam Bandopadhyay; Prabhakar Kumar Singh; Pragya Shakti Mishra; Neha Sharma; Navneet Khurana
Journal:  Metab Brain Dis       Date:  2021-08-13       Impact factor: 3.584

2.  N-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge.

Authors:  Shih Chang Hsueh; Weiming Luo; David Tweedie; Dong Seok Kim; Yu Kyung Kim; Inho Hwang; Jung-Eun Gil; Baek-Soo Han; Yung-Hsiao Chiang; Warren Selman; Barry J Hoffer; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-30

Review 3.  Inhibitors of Src Family Kinases, Inducible Nitric Oxide Synthase, and NADPH Oxidase as Potential CNS Drug Targets for Neurological Diseases.

Authors:  Meghan C Gage; Thimmasettappa Thippeswamy
Journal:  CNS Drugs       Date:  2021-01-30       Impact factor: 5.749

Review 4.  Adaptive responses to neurodegenerative stress in glaucoma.

Authors:  David J Calkins
Journal:  Prog Retin Eye Res       Date:  2021-02-25       Impact factor: 19.704

5.  SARS-CoV-2 Infection of Microglia Elicits Proinflammatory Activation and Apoptotic Cell Death.

Authors:  Gi Uk Jeong; Jaemyun Lyu; Kyun-Do Kim; Young Cheul Chung; Gun Young Yoon; Sumin Lee; Insu Hwang; Won-Ho Shin; Junsu Ko; June-Yong Lee; Young-Chan Kwon
Journal:  Microbiol Spectr       Date:  2022-05-05

6.  Impact of Age on Plasma Inflammatory Biomarkers in the 6 Months Following Mild Traumatic Brain Injury.

Authors:  Hilaire J Thompson; Sarah R Martha; Jin Wang; Kyra J Becker
Journal:  J Head Trauma Rehabil       Date:  2020 Sep/Oct       Impact factor: 3.117

7.  The Elastin-Derived Peptide VGVAPG Does Not Activate the Inflammatory Process in Mouse Cortical Astrocytes In Vitro.

Authors:  Konrad A Szychowski; Jan Gmiński
Journal:  Neurotox Res       Date:  2019-11-05       Impact factor: 3.911

8.  Does Cholinergic Stimulation Affect the P2X7 Receptor-Mediated Dye Uptake in Mast Cells and Macrophages?

Authors:  Dilyara Nurkhametova; Andrei Siniavin; Maria Streltsova; Denis Kudryavtsev; Igor Kudryavtsev; Raisa Giniatullina; Victor Tsetlin; Tarja Malm; Rashid Giniatullin
Journal:  Front Cell Neurosci       Date:  2020-10-28       Impact factor: 5.505

Review 9.  Fasting as a Therapy in Neurological Disease.

Authors:  Matthew C L Phillips
Journal:  Nutrients       Date:  2019-10-17       Impact factor: 5.717

10.  Neuronal Ceroid Lipofuscinosis in a Domestic Cat Associated with a DNA Sequence Variant That Creates a Premature Stop Codon in CLN6.

Authors:  Martin L Katz; Reuben M Buckley; Vanessa Biegen; Dennis P O'Brien; Gayle C Johnson; Wesley C Warren; Leslie A Lyons
Journal:  G3 (Bethesda)       Date:  2020-08-05       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.